These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 2189768)

  • 1. Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans.
    Butler PC; Chou J; Carter WB; Wang YN; Bu BH; Chang D; Chang JK; Rizza RA
    Diabetes; 1990 Jun; 39(6):752-6. PubMed ID: 2189768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.
    Rachman J; Payne MJ; Levy JC; Barrow BA; Holman RR; Turner RC
    Diabetes Care; 1998 May; 21(5):810-6. PubMed ID: 9589246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo glucose-stimulated amylin secretion is increased in nondiabetic patients with pancreatic cancer.
    Mäkimattila S; Hietaniemi K; Kiviluoto T; Timonen T; Yki-Järvinen H
    Metabolism; 2001 Sep; 50(9):1036-42. PubMed ID: 11555835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral antidiabetic agents on plasma amylin level in patients with non-insulin-dependent diabetes mellitus (type 2).
    Zapecka-Dubno B; Czyzyk A; Dworak A; Bak MI
    Arzneimittelforschung; 1999 Apr; 49(4):330-4. PubMed ID: 10337452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of glipizide gastrointestinal therapeutic system on islet cell hormonal responses to a test meal in NIDDM.
    Mooradian AD; Albert SG; Bernbaum M; Plummer S
    Diabetes Care; 1996 Aug; 19(8):883-4. PubMed ID: 8842609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased plasma amylin in type 1 diabetic patients after kidney and pancreas transplantation: A sign of impaired beta-cell function?
    Stadler M; Anderwald C; Karer T; Tura A; Kästenbauer T; Auinger M; Bieglmayer C; Wagner O; Kronenberg F; Nowotny P; Pacini G; Prager R
    Diabetes Care; 2006 May; 29(5):1031-8. PubMed ID: 16644633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease of stimulated amylin release precedes impairment of insulin secretion in type II diabetes.
    Ludvik B; Lell B; Hartter E; Schnack C; Prager R
    Diabetes; 1991 Dec; 40(12):1615-9. PubMed ID: 1756902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperamylinemia is associated with hyperinsulinemia in the glucose-tolerant, insulin-resistant offspring of two Mexican-American non-insulin-dependent diabetic parents.
    Gulli G; Rossetti L; DeFronzo RA
    Metabolism; 1997 Oct; 46(10):1157-61. PubMed ID: 9322799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased activation of skeletal muscle glycogen synthase by mixed-meal ingestion in NIDDM.
    Wright KS; Beck-Nielsen H; Kolterman OG; Mandarino LJ
    Diabetes; 1988 Apr; 37(4):436-40. PubMed ID: 2837418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amylin and the amylin gene: structure, function and relationship to islet amyloid and to diabetes mellitus.
    Cooper GJ; Day AJ; Willis AC; Roberts AN; Reid KB; Leighton B
    Biochim Biophys Acta; 1989 Dec; 1014(3):247-58. PubMed ID: 2690958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of total and nonglycosylated amylin in plasma characterizes subjects with impaired glucose tolerance and type 2 diabetes.
    Mäkimattila S; Fineman MS; Yki-Järvinen H
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2822-7. PubMed ID: 10946889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients.
    Sanke T; Hanabusa T; Nakano Y; Oki C; Okai K; Nishimura S; Kondo M; Nanjo K
    Diabetologia; 1991 Feb; 34(2):129-32. PubMed ID: 2065848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of basal insulin supplementation on disposition of mixed meal in obese patients with NIDDM.
    McMahon M; Marsh HM; Rizza RA
    Diabetes; 1989 Mar; 38(3):291-303. PubMed ID: 2492963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans.
    Hartter E; Svoboda T; Ludvik B; Schuller M; Lell B; Kuenburg E; Brunnbauer M; Woloszczuk W; Prager R
    Diabetologia; 1991 Jan; 34(1):52-4. PubMed ID: 2055340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma amylin immunoreactivity and insulin resistance in insulin resistant relatives of patients with non-insulin-dependent diabetes mellitus.
    Nyholm B; Fineman MS; Koda JE; Schmitz O
    Horm Metab Res; 1998 Apr; 30(4):206-12. PubMed ID: 9623635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of amylin in insulin secretion and action in humans: antagonist studies across the spectrum of insulin sensitivity.
    Mather KJ; Paradisi G; Leaming R; Hook G; Steinberg HO; Fineberg N; Hanley R; Baron AD
    Diabetes Metab Res Rev; 2002; 18(2):118-26. PubMed ID: 11994903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-peptide response to meal challenge in nondiabetic and diabetic adults living in Wadena, Minnesota.
    Bushhouse SA; Goetz FC; Jacobs DR; Bender AP; French LR; Oestreich PG; Geisser MS
    Diabetes Care; 1992 Oct; 15(10):1335-47. PubMed ID: 1425099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amylin/islet amyloid polypeptide: biochemistry, physiology, patho-physiology.
    Castillo MJ; Scheen AJ; Lefèbvre PJ
    Diabete Metab; 1995 Feb; 21(1):3-25. PubMed ID: 7781840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle.
    Cooper GJ; Leighton B; Dimitriadis GD; Parry-Billings M; Kowalchuk JM; Howland K; Rothbard JB; Willis AC; Reid KB
    Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7763-6. PubMed ID: 3051005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-frequency oscillations in circulating amylin concentrations in healthy humans.
    Juhl CB; Pørksen N; Sturis J; Hansen AP; Veldhuis JD; Pincus S; Fineman M; Schmitz O
    Am J Physiol Endocrinol Metab; 2000 Mar; 278(3):E484-90. PubMed ID: 10710503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.